Sulfasalazine-induced Pulmonary Disease - CHEST Sulfasalazine-induced pulmonary disease, although rare, has varying presentations, as illustrated by our patients, and is an important complication to recognize in view of the potential for permanent lung damage and even death
Sulfasalazine-Induced Interstitial Fibrosis - PMC In brief, sulfasalazine-induced pulmonary disease may manifest in different forms Timely detection and prompt treatment prevent pulmonary complications from developing into a life-threatening situation and permit the avoidance of other drug-related adverse effects
Sulphasalazine and lung toxicity - PubMed Typical presentation of sulphasalazine-induced lung disease was with new onset dyspnoea and infiltrates on chest radiography Common symptoms were cough and fever Crepitations on auscultation and peripheral eosinophilia were noted in half of the cases
Sulphasalazine induced lung disease - Thorax We suggest that the possibility of drug-induced lung disease should be considered in any patient who develops symptoms or radiographic evidence of pulmonary disease while receiving treatment with sulphasalazine
Sulfasalazine-induced Pulmonary Disease - ScienceDirect Sulfasalazine-induced pulmonary disease, although rare, has varying presentations, as illustrated by our patients, and is an important complication to recognize in view of the potential for permanent lung damage and even death
Sulfasalazine: A rare cause of acute eosinophilic pneumonia Pulmonary toxicity from sulfasalazine is a rather rare finding Acute eosinophilic pneumonia is characterized by the rapid accumulation of eosinophils in the lung in response to allergens, inflammation or infection Symptom onset is usually rapid and can include dyspnoea, fever, cough and chest pain